After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Deutsche Bank's problems have investors worried about another Lehman failure, Cramer says.
Rumors are swirling about Big Pharma interest in the cancer drug developer, but the validity of such theories is questioned by at least some company followers.
Cramer is sticking with Weyerhaeuser and thinks Taser is a buy.
Some companies have powerful trends to bolster their numbers, Fed or no Fed, Cramer says.
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.